CSBR
Champions Oncology Inc
5.00$
-5.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.9% | +16.5% | +0.4% | -4.1% | +26.3% | -27.5% | +13.3% | +7.4% | +10.1% | -16.4% | +10.1% | – | |
| – | +18.6% | -7.6% | -2.5% | +5.0% | -10.9% | +9.9% | +10.0% | -9.2% | +21.6% | -22.9% | +15.3% | – | |
| – | -15.8% | +61.9% | +3.5% | -13.3% | +72.0% | -51.2% | +18.0% | +29.6% | -0.6% | -9.0% | +5.1% | – | |
| – | -13.1% | -6.3% | -29.0% | +16.2% | +1.8% | +14.2% | +6.1% | +25.6% | -13.2% | -6.9% | +10.8% | – | |
| – | +6.3% | -0.1% | -8.5% | -25.2% | +26.9% | +5.3% | +1.7% | +15.7% | +0.0% | -11.5% | +1.5% | – | |
| – | -2.4% | +4.1% | -19.4% | -5.8% | +11.1% | +14.8% | -4.3% | +16.6% | +4.3% | -3.2% | +1.8% | – | |
| – | – | – | – | -44.9% | +514.6% | -138.1% | – | – | -201.1% | – | – | – | |
| – | – | – | – | -44.6% | +511.4% | -143.5% | – | – | -192.9% | – | – | – | |
| – | +0.0% | -836.4% | – | -47.6% | +109.1% | -660.9% | – | +28.6% | +133.3% | +309.5% | -93.6% | – | |
| – | – | – | – | -44.6% | +517.4% | -140.8% | – | – | -193.3% | – | – | – | |
| – | – | – | +187.1% | -36.2% | +332.0% | -131.9% | – | – | -83.0% | -267.3% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.